Description

According to StrategyHelix, the global pain management market is expected to increase by US$ 37.9 billion during 2022-2028, expanding at a CAGR of 6.3% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for pain management. The global pain management market is segmented on the basis of product, application, and region. Based on product, the global pain management market is categorized into devices, drugs. The drugs segment captured the largest share of the market in 2021. On the basis of application, the global pain management market has been segmented into cancer pain, dental pain, fibromyalgia, general pain, HIV/AIDS pain, migraines, neuropathic pain, musculoskeletal pain, surgical pain, others. The musculoskeletal pain segment held the largest share of the global pain management market in 2021 and is anticipated to hold its share during the forecast period. Geographically, the global pain management market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). In 2021, North America made up the largest share of revenue generated by the pain management market.

The devices market is further segmented into electrotherapy/muscle stimulation, spine stimulators, and others. According to the research, the spine stimulators segment had the largest share in the global pain management market. Furthermore, the drugs market has been categorized into anesthetics, antimigraine agents, CNS treatments, medical cannabis, narcotic analgesics, non-narcotic analgesics, and others. StrategyHelix research indicates that the non-narcotic analgesics segment occupied the largest share of this market in 2021 and is expected to draw the highest demand in coming years.

The global pain management market is highly competitive. Key companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amgen Inc., Aphria Inc., Baxter International Inc., Boston Scientific Corp., Canopy Growth Corporation, Cronos Group, Dr. Reddy’s Laboratories Ltd., Eli Lilly Company, Fresenius Kabi AG, GlaxoSmithKline (GSK), GW Pharmaceuticals plc, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic plc, Merck & Co., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. Competitive landscape gives a description of the competitive nature of the global pain management market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pain management market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: devices, drugs
Application: cancer pain, dental pain, fibromyalgia, general pain, HIV/AIDS pain, migraines, neuropathic pain, musculoskeletal pain, surgical pain, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Abbott Laboratories, AbbVie Inc., Amgen Inc., Aphria Inc., Baxter International Inc., Boston Scientific Corp., Canopy Growth Corporation, Cronos Group, Dr. Reddy’s Laboratories Ltd., Eli Lilly Company, Fresenius Kabi AG, GlaxoSmithKline (GSK), GW Pharmaceuticals plc, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Medtronic plc, Merck & Co., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global pain management market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Pain management market overview
Part 3. Market breakdown by product
– Devices
– Drugs
Part 4. Market breakdown by application
– Cancer pain
– Dental pain
– Fibromyalgia
– General pain
– HIV/AIDS pain
– Migraines
– Neuropathic pain
– Musculoskeletal pain
– Surgical pain
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– Abbott Laboratories
– AbbVie Inc.
– Amgen Inc.
– Aphria Inc.
– Baxter International Inc.
– Boston Scientific Corp.
– Canopy Growth Corporation
– Cronos Group
– Dr. Reddy’s Laboratories Ltd.
– Eli Lilly Company
– Fresenius Kabi AG
– GlaxoSmithKline (GSK)
– GW Pharmaceuticals plc
– Hisamitsu Pharmaceutical Co., Inc.
– Johnson & Johnson
– Medtronic plc
– Merck & Co.
– Novartis AG
– Pfizer Inc.
– Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer